Mena Lora Alfredo J, Burgos Rodrigo, Borgetti Scott, Chaisson Lelia H, Bleasdale Susan C
University of Illinois at Chicago, Chicago, Illinois.
Antimicrob Steward Healthc Epidemiol. 2023 Mar 31;3(1):e63. doi: 10.1017/ash.2023.146. eCollection 2023.
Deploying therapeutics for coronavirus disease 2019 (COVID-19) has proved challenging due to evolving evidence, supply shortages, and conflicting guideline recommendations. We conducted a survey on remdesivir use and the role of stewardship. Use differs significantly from guidelines. Hospitals with remdesivir restrictions were more guideline concordant. Formulary restrictions can be important for pandemic response.
由于证据不断演变、供应短缺以及指南建议相互冲突，为2019冠状病毒病（COVID-19）部署治疗方法已被证明具有挑战性。我们对瑞德西韦的使用情况及管理作用进行了一项调查。其使用情况与指南有显著差异。对瑞德西韦有限制规定的医院更符合指南。药品目录限制对疫情应对可能很重要。
